RVX Chart by TradingView

Business Description

Resverlogix is a biotechnology company focused on the two largest drug markets – cancer and cholesterol. Its unique technology is focused on increasing HDL’s (good cholesterol) as opposed to the more common focus of lowering LDL’s (bad cholesterol).

Website http://www.resverlogix.com/


InvestmentPitch Media Video Discusses Resverlogix’ Enrollment and Dosing of Patients in a Phase 2b Clinical Trial at a Site at the University of Alberta Hospital in Edmonton, to evaluate Apabetalone as a Potential Oral Treatment for COVID-19 – Video Available on Investmentpitch.com Jan. 19, 2022
Resverlogix Announces Commencement of Patient Enrollment and Dosing in a Phase 2b Trial for a Promising Canadian-Developed COVID-19 Treatment Jan. 18, 2022
How Much Of Resverlogix Corp. (TSE:RVX) Do Institutions Own? Dec. 29, 2021
Resverlogix: The Future of Drug Development, CEO Clip Video Dec. 16, 2021
Resverlogix Announces Corporate Update Webcast and Conference Call Dec. 13, 2021